This study examined a new model of paclitaxel-induced neuropathic pain and the effects of systemic paclitaxel on the gap junction protein subunit Cx43 and potassium inwardly-rectifying channel Kir4.1 within the dorsal root ganglia. In the new neuropathic pain model, subplantar injections of paclitaxel resulted in decreased conduction velocities of A-beta fiber compound action potentials in the sciatic (5.9%) and tibial nerves (6.8%) as well as in M (10.6%) and H (10.2%) waves. By using repeated recordings it was found that following paclitaxel injection, conduction velocities in the contralateral plantar nerve increased (9.2%). Systemic injections of paclitaxel resulted in reduced Kir4.1 immunolabeling in the dorsal root ganglia compared to vehicle injections. This reduction was observed in total labeling (32.4%) as well as in areas of intense labeling (28.7%). Reductions in overall Cx43 immunolabeling (25%) and area (25%) following systemic paclitaxel injections were not statistically significant. The results of these studies suggest that subplantar injections of paclitaxel can result in reduced peripheral nerve conduction velocities. The results also show that a unilateral neuropathy can result in contralateral changes in conduction velocities. The effects of paclitaxel on reducing Kir4.1 levels suggest that neuropathic pain caused by paclitaxel may share mechanisms in common with …